Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Expanding diagnostics footprint in East India
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)
Includes thermostabilized Ebola vaccines
A primary investment of Rs 194.4 crore has been made
Subscribe To Our Newsletter & Stay Updated
